Condition

Plasma Cell Myeloma clinical trials and research

• 8Clinical trials
• 2Countries

Newest Plasma Cell Myeloma clinical trials

All recruiting trials (8)

• Imaging for detecting cancer cells in multiple myeloma

  This study is testing a new imaging agent to see if it can better detect cancer cells in people with multiple myeloma compared to standard imaging methods.

  Recruiting Phase 1 University of California, San Francisco · San Francisco, California · NCT05892393

• Comparing drug combinations for treating newly diagnosed multiple myeloma in patients not suitable for stem cell transplant

  This study is testing different combinations of three drugs to see which works best for people with newly diagnosed multiple myeloma who can't have a stem cell transplant.

  Recruiting at 388 sites Phase 3 SWOG Cancer Research Network · Anchorage, Alaska and 396 other locations · NCT05561387

• Improving quality of life and immune function in multiple myeloma patients through lifestyle changes

  This study is testing whether lifestyle changes like exercise and diet can improve the immune system and quality of life for people with multiple myeloma.

  Recruiting Roswell Park Cancer Institute · Buffalo, New York · NCT05312255

• Combination treatment for high-risk myeloma using belantamab mafodotin, pomalidomide, and dexamethasone

  This study is testing a new combination of three medications to see if it can help people with high-risk plasma cell myeloma feel better and improve their treatment outcomes.

  Recruiting Phase 2 Emory University · Atlanta, Georgia · NCT05208307

• Assessing cognitive effects of whole brain radiation therapy in blood cancer patients

  This study is testing how whole brain radiation therapy affects thinking and memory in blood cancer patients, while also looking at quality of life and brain changes over time.

  Recruiting M.D. Anderson Cancer Center · Houston, Texas · NCT05011045

• Combining four drugs to treat newly diagnosed multiple myeloma

  This study is testing if adding a fourth drug to a three-drug treatment helps adults with newly diagnosed multiple myeloma live longer and feel better.

  Recruiting at 303 sites Phase 3 Eastern Cooperative Oncology Group · Anchorage, Alaska and 646 other locations · NCT04566328

• Using loratadine to reduce bone pain from G-CSF in multiple myeloma patients during stem cell mobilization

  This study is testing if taking loratadine can help reduce bone pain in multiple myeloma patients who are receiving G-CSF during stem cell collection.

  Recruiting Early Phase 1 Rutgers, The State University of New Jersey · New Brunswick, New Jersey and 1 other locations · NCT04211259

• Low-dose radiotherapy for painful bone metastases in multiple myeloma patients

  This study is testing if low-dose radiation therapy can help reduce bone pain in patients with multiple myeloma that has spread to their bones.

  Recruiting at 9 sites University of Southern California · Duarte, California and 8 other locations · NCT03858205

Related topics

Quick answers

How many Plasma Cell Myeloma clinical trials are recruiting right now?

8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (8 trials), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2, Early Phase 1: 1, Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →